UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...
SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...
Zhang, X. and Zeng, X. (2025) Diagnostic Challenges and Multidisciplinary Management Strategies for Manicure-Induced ...
Kittredge had the debridement procedure on Friday. The Orioles said Saturday the operation was done by Dr. SARASOTA, Fla. (AP) — Baltimore Orioles reliever Andrew Kittredge will miss the start of the ...
SolasCure has initiated a new Phase II clinical trial, CLEANVLU2, to further the development of its investigational product, ...